Search results
AbbVie Inc. (NYSE:ABBV) Shares Bought by Childress Capital Advisors LLC
ETF DAILY NEWS· 5 days agoChildress Capital Advisors LLC raised its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.8% during the fourth quarter, according to the company in its most recent ...
Scarborough Advisors LLC Takes $1.38 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoScarborough Advisors LLC bought a new stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) in the 4th quarter, Holdings Channel reports. The firm bought 8,907 shares of ...
AbbVie and FutureGen link on inflammatory bowel disease
Pharmaceutical Technology via Yahoo Finance· 5 days agoAbbVie has made a licence agreement with FutureGen Biopharmaceutical to develop a next-generation...
Security National Bank of SO Dak Purchases 102 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoSecurity National Bank of SO Dak lifted its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the 4th quarter, according to the company in its most recent Form ...
Raleigh Capital Management Inc. Has $2.67 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoRaleigh Capital Management Inc. grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.9% during the 4th quarter, according to the company in its most recent disclosure ...
Gateway - Quartz
Quartz· 21 hours agoPharmaceutical giant AbbVie was able to delay competition to its blockbuster arthritis drug, Humira, into the US market for many years. Although biosimilars will sell at a ...
Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades' - NVIDIA...
Benzinga· 2 days agoOn CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex...
AbbVie joins in latest gastrointestinal drug chase
BioPharma Dive via Yahoo Finance· 5 days agoAbbVie is securing its place in an emerging gastrointestinal disease drug field, paying China-based FutureGen Biopharmaceutical $150 million in immediate...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks· 5 days agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop FG-M701, a next-generation TL1A antibody, for IBD indications.
State Farm Mutual Automobile Insurance Co. Has $961.26 Million Stock Holdings in AbbVie Inc....
ETF DAILY NEWS· 7 days agoState Farm Mutual Automobile Insurance Co. decreased its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.8% during the 4th quarter, according to the company in its ...
